Interference of anti-tumor and immunosuppressive effects of cyclophosphamide in tumor-bearing rats

[1]  F. Culo,et al.  The timing of cyclophosphamide therapy in tumor-bearing rats affects the resistance to tumor challenge in survivors , 1978, Experientia.

[2]  R. Lubet,et al.  Therapy of the murine plasmacytoma MOPC 104E: role of the immune response. , 1978, Journal of the National Cancer Institute.

[3]  I. Maclennan,et al.  Analysis of synergy between cyclophosphamide Therapy and Immunity Against a Mouse Tumour , 1978, British Journal of Cancer.

[4]  R. Lubet,et al.  Tumor immunity directed against MOPC 104E: Effect of various therapeutic regimens , 1977, Cancer Immunology, Immunotherapy.

[5]  F. Culo,et al.  Lymphotoxic effect of cyclophosphamide in therapy of Ehrlich ascites carcinoma in mice. , 1977, Journal of the National Cancer Institute.

[6]  G. Mathé,et al.  Effectiveness of murine leukemia chemotherapy according to the immune state , 1977, Cancer Immunology, Immunotherapy.

[7]  M. Moore,et al.  Contribution of host immunity to cyclophosphamide therapy of a chemically‐induced murine sarcoma , 1973, International journal of cancer.

[8]  F. Rapp,et al.  Effect of cyclophosphamide on syngeneic transplantation of para‐adenovirus‐7‐transformed tumor cells in hamsters , 1972, International journal of cancer.

[9]  W. Dewys.  A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide. , 1972, Cancer research.

[10]  S. Bremberg.  The influence of host factors on cyclophosphamide treatment of Moloney virus-induced lymphomas. , 1970, European journal of cancer.

[11]  A. Goldin,et al.  Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity. , 1970, Cancer research.

[12]  W. Boyle.  AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINS , 1968, Transplantation.

[13]  K. Sugiura,et al.  Antitumor activity of cytoxan. , 1961, Cancer research.

[14]  J. Miller,et al.  Studies on Mouse Leukaemia. The Role of the Thymus in Leukaemogenesis by Cell-free Leukaemic Filtrates , 1960, British Journal of Cancer.

[15]  H. Stewart,et al.  A survey of transplantable and transmissible animal tumors. , 1953, Journal of the National Cancer Institute.

[16]  M. Mokyr,et al.  Importance of timing of cyclophosphamide (cy) therapy for curing mopc-315 tumor-bearing mice. Abstr. , 1980 .

[17]  G. Santos.  Application of Marrow Grafts in Human Disease: Its Problems and Potential , 1972 .

[18]  De Wys.  A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide. , 1972 .